Document is current
Any future updates will be listed below
-
Authors
Emara, Moataz Maher https://orcid.org/0000-0001-8911-1812
Elsawy, Neamat Hamdy
Abdelaaty, Kholoud M.
Elhamaky, Amal Salah
Eltahan, Naglaa Hamdi
-
Funding
Funding for this research was provided by:
Mansoura University
- License Information
-
More Information
Article History
Received: 17 January 2022
Accepted: 2 August 2022
First Online: 8 August 2022
Declarations
:
: We obtained the IRB approval (No. R.21.04.1300) at Mansoura University, Faculty of Medicine on June 2, 2021 (Supplement S).Written informed consent was received either from the patient or the legal representative if the patient is unable to provide consent.One of the investigators conducted the consent process with the patient or the legal representative by signing two copies (one for the investigator and one for the patient). The consent was signed and dated by both the conducting investigator and the patient side.Patients or their legal representatives (in the case of unconscious patients) were informed clearly that all patients have the same chances to receive the active treatment or the placebo.
: We received a consent for publication along with the consent for participation (Item 13 in the consent form, supplement S).
: All authors declare that they have no competing interests.
